Alnardo Lora 🇩🇴
@crzydoc
🫁 Fellow @HarvardPulm @MGH_PCCM @PCCSM_BIDMC | Former Chief Resident @SUNYDownstate via @Unibeenlinea | Social Justice | ΛΣΥ ΑΩΑ
ID:43968045
01-06-2009 20:44:06
5,7K Tweets
3,0K Followers
3,3K Following
Follow People
The world’s first genetically edited pig kidney transplant into a living recipient was performed at Mass General last Saturday. Years of research, pre-clinical studies and collaboration by Mass General Transplant has led to this historic achievement. Learn more from the The New York Times:
Excellent Journal Club discussions today by F2 Louisa Mounsey and F1 Michael Kelly on the BOREAS & ENHANCE trials for COPD! Drs. Mounsey and Kelly did a great job presenting the strengths/weaknesses of each trial and placing the results in context with current clinical practices.
In a recent Science Magazine publication, researchers from Ragon Institute MGH Division of Infectious Diseases and colleagues found a link between smoking and the immune cells that invade the lungs, and it may increase the risk of tuberculosis.
Read more: massgeneral.org/news/press-rel… MedoffLab Doug Kwon
F3 Drs. Marvah Hill Pierre-Louis (Marvah Hill) and Raymond Parrish led a great journal club discussion about the use of phage therapy in patients with drug-resistant mycobacterial disease (pubmed.ncbi.nlm.nih.gov/35676823/) and rituximab in patients with ILD, NSIP (pubmed.ncbi.nlm.nih.gov/37230499/)
We are absolutely delighted to welcome this amazing class of new fellows to the MGH/BIDMC Pulmonary and Critical Care Medicine Fellowship in July 2024!
MGH Division of Pulmonary & Critical Care Medicine
BIDMC Pulmonary, Critical Care, and Sleep Medicine
Congrats 👏 to Dr. Grace Lisius for leading the paper in iScience journal studying plasma microbial cell-free DNA (mcfDNA) 🩸🦠🧬 in patients with #COVID19 pubmed.ncbi.nlm.nih.gov/37965142/
Simple ?: is it just #Covid or is there bacterial/fungal superinfection?
Answer not so simple... 🧵
Great Grand Rounds by F1 Mike Kelly about drug-induced lung injury! A patient with metastatic breast cancer sought care for worsening dyspnea, and it was determined to be due to toxicity related to trastuzumab deruxtecan, an antibody-drug conjugate for cancer treatment.